New combined hepatitis A and B vaccineBMJ 1997; 315 doi: https://doi.org/10.1136/bmj.315.7113.951 (Published 11 October 1997) Cite this as: BMJ 1997;315:951
- Martin Dedicoat (martded@AOL.com), Specialist registrara,
- Christopher J Ellis, Consultant physiciana
- a Department of Infection and Tropical Medicine, Birmingham Heartlands Hospital, Birmingham B9 5SS
Editor—Recently a new combined hepatitis A and B vaccine has been introduced (Twinrix; SmithKline Beecham) and widely promoted in the lay press for travellers to insanitary regions of the world, often with little or no regard for the duration of travel. We believe that the use of vaccines by travellers should be evidence based, in this case based on evidence of infection in returning travellers.
Over the past 12 months this regional infectious disease …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial